FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 65 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $85,000 | +9.0% | 25,533 | -0.2% | 0.00% | – |
| Q3 2019 | $78,000 | +44.4% | 25,573 | +12.2% | 0.00% | – |
| Q2 2019 | $54,000 | -37.2% | 22,796 | -0.1% | 0.00% | – |
| Q1 2019 | $86,000 | +2.4% | 22,818 | -1.9% | 0.00% | – |
| Q4 2018 | $84,000 | -38.2% | 23,271 | -1.9% | 0.00% | – |
| Q3 2018 | $136,000 | +74.4% | 23,733 | +51.8% | 0.00% | – |
| Q2 2018 | $78,000 | +18.2% | 15,635 | +20.7% | 0.00% | – |
| Q1 2018 | $66,000 | -17.5% | 12,954 | -2.1% | 0.00% | – |
| Q4 2017 | $80,000 | -64.1% | 13,234 | -45.1% | 0.00% | – |
| Q3 2016 | $223,000 | -83.4% | 24,091 | -88.3% | 0.00% | – |
| Q1 2016 | $1,341,000 | -19.4% | 205,644 | +0.2% | 0.00% | -100.0% |
| Q4 2015 | $1,664,000 | +14.6% | 205,200 | +3.6% | 0.00% | – |
| Q3 2015 | $1,452,000 | +664.2% | 197,986 | +968.5% | 0.00% | – |
| Q2 2015 | $190,000 | – | 18,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 20,150 | $0 | 0.00% |
| Advisory Services Network, LLC | 2,233 | $0 | 0.00% |
| Fernwood Investment Management, LLC | 34,000 | $0 | 0.00% |